Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Med. 2013 Dec;2(6):972-7. doi: 10.1002/cam4.156. Epub 2013 Nov 7.

Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients.

Author information

  • 1Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi, Ibaraki, Osaka, 567-0085, Japan.

Abstract

Eph receptor A10 (EphA10) is a valuable breast cancer marker that is highly expressed in breast cancer tissues by comparison with normal breast tissues, as we previously reported. However, the role of EphA10 expression in breast cancer is not well understood. Here, we have analyzed the expression of EphA10 at the mRNA- and protein-level in clinical breast cancer tissues and then evaluated the relationship with clinicopathological parameters for each sample. EphA10 mRNA expression was quantified by real-time polymerase chain reaction using complimentary DNA (cDNA) samples derived from breast cancer patients. Lymph node (LN) metastasis and stage progression were significantly correlated with EphA10 expression at the mRNA level (P = 0.0091 and P = 0.034, respectively). Furthermore, immunohistochemistry (IHC) staining of breast cancer tissue microarrays (TMAs) revealed that EphA10 expression at the protein level was also associated with LN metastasis and stage progression (P = 0.016 and P = 0.011, respectively). These results indicate that EphA10 expression might play a role in tumor progression and metastasis. Our findings will help elucidate the role of EphA10 in clinical breast cancer progression.

© 2013 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

KEYWORDS:

Breast cancer; Eph receptor A10; lymph node metastasis

PMID:
24403271
[PubMed - indexed for MEDLINE]
PMCID:
PMC3892402
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk